Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.

Arch Gynecol Obstet · 2022 · PMC9411224 · PMID 35237856

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not quite reach the level of significanceno p-value reported

Although miR-200c did not quite reach the level of significance in terms of alpha 5%, it is important not to neglect its involvement in the pathomechanisms of breast cancer, especially with regard to its genetic location.

also in 16 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.